MedPath

Radiation Therapy in Treating Women With Localized Breast Cancer

Not Applicable
Completed
Conditions
Breast Cancer
Interventions
Radiation: Radiation therapy
Registration Number
NCT00107497
Lead Sponsor
Institute of Cancer Research, United Kingdom
Brief Summary

RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Giving radiation therapy in different ways and giving it after surgery may kill any tumor cells that remain after surgery.

PURPOSE: This randomized clinical trial is studying radiation therapy to see how well it works in treating women with localized breast cancer.

Detailed Description

OBJECTIVES:

* Compare late normal tissue effects of standard vs 2 different dose levels of hypofractionated adjuvant whole breast radiotherapy, in terms of changes in photographic breast appearance, in women with localized breast cancer who are at average or low risk of recurrence.

* Compare tumor control in patients treated with these regimens.

OUTLINE: This is a randomized, multicenter study. Patients are stratified according to participating center. Patients are randomized to 1 of 3 treatment arms.

* Arm I (control): Patients undergo standard radiotherapy 5 days a week for 5 weeks.

* Arm II: Patients undergo hypofractional radiotherapy once a week for 5 weeks.

* Arm III: Patients undergo hypofractional radiotherapy (at a lower dose than arm II) once a week for 5 weeks.

After completion of study treatment, patients are followed annually for 5-10 years.

PROJECTED ACCRUAL: A total of 900 patients (300 per treatment arm) will be accrued for this study within 12 months.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
917
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Test group 2Radiation therapy28.5Gy in 5 fractions of radiation therapy over 5 weeks
ControlRadiation therapy50Gy in 25 fractions of radiation therapy over 5 weeks
Test group 1Radiation therapy30Gy in 5 fractions of radiation therapy over 5 weeks
Primary Outcome Measures
NameTimeMethod
Change in photographic breast appearance2 years post randomisation

Change in photographic breast appearance at 2 years post randomisation compared to a baseline pre-surgical photograph

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (19)

Southend University Hospital NHS Foundation Trust

🇬🇧

Westcliff-On-Sea, England, United Kingdom

Royal Shrewsbury Hospital

🇬🇧

Shrewsbury, England, United Kingdom

University Hospital of North Staffordshire

🇬🇧

Stoke-On-Trent, England, United Kingdom

Royal Marsden NHS Foundation Trust - Surrey

🇬🇧

Sutton, England, United Kingdom

Torbay Hospital

🇬🇧

Torquay Devon, England, United Kingdom

Worthing Hospital

🇬🇧

Worthing, England, United Kingdom

Velindre Cancer Center at Velindre Hospital

🇬🇧

Cardiff, Wales, United Kingdom

Sussex Cancer Centre at Royal Sussex County Hospital

🇬🇧

Brighton, England, United Kingdom

Cumberland Infirmary

🇬🇧

Carlisle, England, United Kingdom

Royal Devon and Exeter Hospital

🇬🇧

Exeter, England, United Kingdom

Cheltenham General Hospital

🇬🇧

Cheltenham, England, United Kingdom

Ipswich Hospital NHS Trust

🇬🇧

Ipswich, England, United Kingdom

Clatterbridge Centre for Oncology NHS Trust

🇬🇧

Merseyside, England, United Kingdom

Christie Hospital NHS Trust

🇬🇧

Manchester, England, United Kingdom

Berkshire Cancer Centre at Royal Berkshire Hospital

🇬🇧

Reading, England, United Kingdom

Royal Cornwall Hospital

🇬🇧

Truro, Cornwall, England, United Kingdom

Worcester Royal Hospital

🇬🇧

Worcester, England, United Kingdom

Halton Hospital - North Cheshire Hospitals NHS Trust

🇬🇧

Cheshire, United Kingdom

Hereford Hospitals NHS Trust

🇬🇧

Hereford, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath